Takeo Ishiyama

1.2k total citations
18 papers, 995 citations indexed

About

Takeo Ishiyama is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Genetics. According to data from OpenAlex, Takeo Ishiyama has authored 18 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Takeo Ishiyama's work include Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Takeo Ishiyama is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Takeo Ishiyama collaborates with scholars based in Japan and United States. Takeo Ishiyama's co-authors include Akira Itô, Tadashi Ishibashi, Kumiko Tokuda, Yukihiro Ohno, Hiroyuki Nishikawa, Tomoko Horisawa, Mutsuo Taiji, Takeshi Enomoto, Hiroshi Mitsumoto and Ikutaro Saji and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Takeo Ishiyama

18 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeo Ishiyama Japan 14 420 378 270 136 118 18 995
Masatomo Ishikawa Japan 15 326 0.8× 170 0.4× 381 1.4× 125 0.9× 119 1.0× 27 950
Orlando Ghirardi Italy 26 420 1.0× 121 0.3× 460 1.7× 128 0.9× 176 1.5× 45 1.4k
Paul Janssen Netherlands 4 520 1.2× 459 1.2× 321 1.2× 129 0.9× 86 0.7× 6 995
Silke Miller United States 15 395 0.9× 204 0.5× 260 1.0× 334 2.5× 133 1.1× 24 1.1k
M. N. Subhash India 18 318 0.8× 187 0.5× 250 0.9× 112 0.8× 76 0.6× 46 870
F.P. Bymaster United States 12 543 1.3× 306 0.8× 402 1.5× 191 1.4× 131 1.1× 27 997
Mitsutaka Nakamura Japan 20 725 1.7× 567 1.5× 373 1.4× 189 1.4× 145 1.2× 60 1.5k
Masahiko Tatsumi Japan 20 827 2.0× 419 1.1× 663 2.5× 233 1.7× 256 2.2× 33 2.0k
Smulevich Ab Russia 11 596 1.4× 517 1.4× 428 1.6× 116 0.9× 153 1.3× 72 1.3k
Marie‐Bernadette Assié France 19 765 1.8× 208 0.6× 500 1.9× 122 0.9× 77 0.7× 25 1.1k

Countries citing papers authored by Takeo Ishiyama

Since Specialization
Citations

This map shows the geographic impact of Takeo Ishiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeo Ishiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeo Ishiyama more than expected).

Fields of papers citing papers by Takeo Ishiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeo Ishiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeo Ishiyama. The network helps show where Takeo Ishiyama may publish in the future.

Co-authorship network of co-authors of Takeo Ishiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Takeo Ishiyama. A scholar is included among the top collaborators of Takeo Ishiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeo Ishiyama. Takeo Ishiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Murai, Takeshi, et al.. (2013). Effects of a dopamine D1 agonist on ketamine-induced spatial working memory dysfunction in common marmosets. Behavioural Brain Research. 249. 109–115. 31 indexed citations
2.
Murai, Takeshi, et al.. (2013). Effects of lurasidone on executive function in common marmosets. Behavioural Brain Research. 246. 125–131. 20 indexed citations
3.
Horisawa, Tomoko, Hiroyuki Nishikawa, Atsushi Ikeda, et al.. (2013). The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone. Behavioural Brain Research. 244. 66–69. 46 indexed citations
4.
Murai, Takeshi, et al.. (2013). Lack of dopamine D4 receptor affinity contributes to the procognitive effect of lurasidone. Behavioural Brain Research. 261. 26–30. 25 indexed citations
5.
Werner, P., Takeo Ishiyama, Antony Loebel, et al.. (2013). 1053 – In Vitro Receptor-binding Profile Of Lurasidone And Other Commonly-used Antipsychotics. European Psychiatry. 28(S1). 1 indexed citations
6.
Ishiyama, Takeo, et al.. (2013). Identification of a Novel Benzoxazolone Derivative as a Selective, Orally Active 18 kDa Translocator Protein (TSPO) Ligand. Journal of Medicinal Chemistry. 56(20). 8191–8195. 15 indexed citations
7.
Ishiyama, Takeo, et al.. (2012). Design, synthesis and structure–activity relationships of novel benzoxazolone derivatives as 18 kDa translocator protein (TSPO) ligands. Bioorganic & Medicinal Chemistry. 20(18). 5568–5582. 31 indexed citations
8.
Horisawa, Tomoko, Takeo Ishiyama, Michiko Ono, Tadashi Ishibashi, & Mutsuo Taiji. (2012). Binding of lurasidone, a novel antipsychotic, to rat 5-HT7 receptor: Analysis by [3H]SB-269970 autoradiography. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 40. 132–137. 22 indexed citations
9.
Ishiyama, Takeo, et al.. (2012). Design, synthesis and structure–activity relationship of novel tricyclic benzimidazolone derivatives as potent 18 kDa translocator protein (TSPO) ligands. Bioorganic & Medicinal Chemistry. 21(5). 1257–1267. 13 indexed citations
10.
11.
Ishibashi, Tadashi, Tomoko Horisawa, Kumiko Tokuda, et al.. (2010). Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity. Journal of Pharmacology and Experimental Therapeutics. 334(1). 171–181. 347 indexed citations
12.
Ishiyama, Takeo, et al.. (2007). Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test. European Journal of Pharmacology. 572(2-3). 160–170. 150 indexed citations
13.
Enomoto, Takeshi, et al.. (2007). Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats. Behavioural Brain Research. 186(2). 197–207. 112 indexed citations
14.
Ishiyama, Takeo, et al.. (2004). Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease. Brain Research. 1019(1-2). 226–236. 33 indexed citations
15.
16.
Ishiyama, Takeo, et al.. (2001). Role of brain‐derived neurotrophic factor in wobbler mouse motor neuron disease. Muscle & Nerve. 24(4). 474–480. 32 indexed citations
17.
Mitsumoto, Hiroshi, et al.. (2001). Effects of cardiotrophin‐1 (CT‐1) in a mouse motor neuron disease. Muscle & Nerve. 24(6). 769–777. 25 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masatomo Ishikawa Breakdown of academic impact, for papers by Orlando Ghirardi Breakdown of academic impact, for papers by Paul Janssen Breakdown of academic impact, for papers by Silke Miller Breakdown of academic impact, for papers by M. N. Subhash Breakdown of academic impact, for papers by F.P. Bymaster Breakdown of academic impact, for papers by Mitsutaka Nakamura Breakdown of academic impact, for papers by Masahiko Tatsumi Breakdown of academic impact, for papers by Smulevich Ab Breakdown of academic impact, for papers by Marie‐Bernadette Assié
Rankless by CCL
2026